tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
Holding VYGR?
Track your performance easily

Voyager Therapeutics (VYGR) Financial Statements

639 Followers

Voyager Therapeutics Financial Overview

Voyager Therapeutics's market cap is currently ―. The company's EPS TTM is $0.72; its P/E ratio is 7.31; Voyager Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 24.60M$ 29.60M$ 19.52M$ 90.06M$ 4.61M
Gross Profit$ 24.60M$ 29.60M$ 19.50M$ 90.06M$ 4.61M
EBIT$ -9.00M$ -10.12M$ -16.18M$ 54.06M$ -29.51M
EBITDA$ -7.87M$ -6.79M$ -14.99M$ 55.40M$ -28.56M
Net Income Common Stockholders$ -9.04M$ -10.12M$ -11.33M$ 56.40M$ -25.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 345.36M$ 371.02M$ 399.57M$ 230.88M$ 252.94M
Total Assets$ 426.04M$ 436.23M$ 469.59M$ 351.28M$ 294.65M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -345.36M$ -371.02M$ -399.57M$ -230.88M$ -252.94M
Total Liabilities$ 95.73M$ 100.81M$ 128.71M$ 114.96M$ 118.43M
Stockholders Equity$ 330.31M$ 335.37M$ 340.90M$ 236.32M$ 176.22M
Cash Flow-
Free Cash Flow$ -28.23M$ -32.55M$ 56.63M$ -24.52M$ -21.83M
Operating Cash Flow$ -27.97M$ -31.58M$ 58.77M$ -23.76M$ -21.05M
Investing Cash Flow$ 64.35M$ -35.94M$ -96.06M$ 26.83M$ -158.30M
Financing Cash Flow$ 14.00K$ 571.00K$ 112.86M$ 460.00K$ 331.00K
Currency in USD

Voyager Therapeutics Earnings and Revenue History

Voyager Therapeutics Debt to Assets

Voyager Therapeutics Cash Flow

Voyager Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis